BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update
by Danessa Lincoln · The Markets DailyBriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report) saw a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 400 shares, a decline of 87.5% from the August 31st total of 3,200 shares. Based on an average trading volume of 102,100 shares, the short-interest ratio is currently 0.0 days.
BriaCell Therapeutics Price Performance
Shares of BCTXW stock remained flat at $0.30 on Friday. The stock had a trading volume of 21,086 shares, compared to its average volume of 59,957. The stock’s fifty day moving average price is $0.23 and its 200 day moving average price is $0.56. BriaCell Therapeutics has a 1-year low of $0.11 and a 1-year high of $2.60.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
Featured Stories
- Five stocks we like better than BriaCell Therapeutics
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Best Stocks Under $10.00
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?